GSK receives FDA orphan drug designation for kidney disease treatment

August 29, 2025 12:08 PM EDT Send to a Friend
The U.S. Food and Drug Administration granted orphan drug designation to a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login